Page last updated: 2024-09-03

2-pyrrolino-dox and Cancer of Liver

2-pyrrolino-dox has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Halmos, G; Schally, AV; Seitz, S; Szepeshazi, K; Treszl, A	1

Other Studies

1 other study(ies) available for 2-pyrrolino-dox and Cancer of Liver

Article	Year
Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin. Anti-cancer drugs, 2008, Volume: 19, Issue:4 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bombesin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Gonadotropin-Releasing Hormone; Humans; Immunohistochemistry; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Radioligand Assay; Receptors, Bombesin; Receptors, LHRH; Receptors, Somatostatin; Transplantation, Heterologous	2008

Article

Year

Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.

Anti-cancer drugs, 2008, Volume: 19, Issue:4

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bombesin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Gonadotropin-Releasing Hormone; Humans; Immunohistochemistry; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Radioligand Assay; Receptors, Bombesin; Receptors, LHRH; Receptors, Somatostatin; Transplantation, Heterologous

2008